Bepanthen Versus Cetomacrogol in Epidermal Growth Factor Receptor Inhibitors (EGFRI) (BeCet)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2013 by Waterland Hospital
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Christine B Boers-Doets, Waterland Hospital
ClinicalTrials.gov Identifier:
NCT01136005
First received: June 2, 2010
Last updated: June 11, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
No publications provided by Waterland Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):